Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Regulation01:25

Drug Regulation

1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

144
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
144
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

699
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
699
Clinical Trials: Overview01:11

Clinical Trials: Overview

2.8K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.8K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Call to Action: Antihunger and Public Health Communities Must Find Common Ground to Advance a More Just and Nutritious Food System in the United States.

American journal of public health·2026
Same author

Integrating patient and public involvement to strengthen oncology research in sub-Saharan Africa.

BMJ oncology·2026
Same author

Patient Expectations for Patient-reported Outcomes After Total Knee Arthroplasty Surpass Actual Outcomes and Correlate With Dissatisfaction.

Arthroplasty today·2026
Same author

Determinants of COVID-19 vaccine hesitancy across 186 countries: a multifaceted analysis using structural equation modeling.

Vaccine·2026
Same author

Federal Funding Cuts Threaten US Pediatric Health.

JAMA pediatrics·2026
Same author

A healthy cities agenda for extreme heat adaptation in urban settings.

Bulletin of the World Health Organization·2026
Same journal

The Potential for Bioactive Peptide Production in a Fermented Dairy Beverage Based on Chickpea Water Extract Using Proteolytic Lactic Acid Bacteria.

Foods (Basel, Switzerland)·2026
Same journal

Influence of Protein Concentration on Heat-Induced Fouling of Oat Drink.

Foods (Basel, Switzerland)·2026
Same journal

Microalgae as Future Foods: Unlocking Their Potential and Overcoming Barriers to Market Adoption and Commercialization.

Foods (Basel, Switzerland)·2026
Same journal

Effect of High-Intensity Ultrasound and Calcium Chelation on Functional Properties of Casein Micelles.

Foods (Basel, Switzerland)·2026
Same journal

GC-MS and GC-IMS Based Metabolomics Combined with Cellular Assays to Characterize Volatile Compounds and Pharmacological Activity of <i>Lysimachia foenum-graecum</i> Hance from Different Origins.

Foods (Basel, Switzerland)·2026
Same journal

Research on the Potential Mechanism of Guanine Nucleotides Enhancing the Tolerance of <i>Lactiplantibacillus plantarum</i> Y12.

Foods (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: Jun 9, 2025

Errors as a Means of Reducing Impulsive Food Choice
07:07

Errors as a Means of Reducing Impulsive Food Choice

Published on: June 5, 2016

8.6K

Restructuring the FDA's Food Program: Promises and Pitfalls.

Sammer Marzouk1, Kranti C Rumalla1, Peter G Lurie2

  • 1Department of Medicine, Northwestern Feinberg School of Medicine, Chicago, IL 60611, USA.

Foods (Basel, Switzerland)
|October 26, 2024
PubMed
Summary
This summary is machine-generated.

The US Food and Drug Administration reorganized its food program after a Cronobacter sakazakii infant formula outbreak. These changes aim to improve the Human Foods Program and public health impact.

Keywords:
Human Foods ProgramUS Food and Drug Administrationinfant formulapublic policyregulationreorganization

More Related Videos

A Treatment Package without Escape Extinction to Address Food Selectivity
04:23

A Treatment Package without Escape Extinction to Address Food Selectivity

Published on: August 21, 2015

11.5K
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

5.8K

Related Experiment Videos

Last Updated: Jun 9, 2025

Errors as a Means of Reducing Impulsive Food Choice
07:07

Errors as a Means of Reducing Impulsive Food Choice

Published on: June 5, 2016

8.6K
A Treatment Package without Escape Extinction to Address Food Selectivity
04:23

A Treatment Package without Escape Extinction to Address Food Selectivity

Published on: August 21, 2015

11.5K
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

5.8K

Area of Science:

  • Food Safety
  • Public Health Policy
  • Regulatory Science

Background:

  • An outbreak of Cronobacter sakazakii infection linked to infant formula prompted regulatory review.
  • The US Food and Drug Administration (FDA) initiated a comprehensive assessment of its food safety protocols.
  • Previous structures necessitated significant reform to address emerging public health threats effectively.

Purpose of the Study:

  • To detail the organizational changes implemented within the FDA's food program.
  • To analyze the anticipated benefits of the new Human Foods Program.
  • To identify further necessary actions for enhancing the FDA's public health influence.

Main Methods:

  • Review of commissioned reports and internal assessments.
  • Analysis of the FDA's food program reorganization strategy.
  • Evaluation of the potential impact of the new program on public health outcomes.

Main Results:

  • Implementation of a major reorganization of the FDA's food program, effective October 1, 2024.
  • Anticipated improvements in the oversight and safety functions of the new Human Foods Program.
  • Identification of key areas requiring further development to bolster the agency's public health mission.

Conclusions:

  • The FDA's food program restructuring is a significant step towards enhanced food safety.
  • Continued efforts are crucial to maximize the effectiveness of the new Human Foods Program.
  • Proactive measures and strategic enhancements are vital for the agency's sustained impact on public health.